Brooks Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	0.43	1.26	0.23	26.05	8.84
Cash & Short-Term Investments	10.51	0.43	1.26	0.23	26.05	8.84
Cash Growth	29.95%	-65.42%	440.95%	-99.11%	194.72%	123.21%
Accounts Receivable	-	199.92	163.16	127.54	176.62	136.98
Other Receivables	-	11.4	17.65	3.03	13.69	4.37
Receivables	-	211.33	180.84	130.57	190.31	141.35
Inventory	-	92.05	96.11	113.03	275.22	236.03
Prepaid Expenses	-	0.83	0.93	0.94	1.77	1.87
Other Current Assets	-	34.12	31.36	31.29	118.47	110.74
Total Current Assets	-	338.77	310.48	276.06	611.82	498.83
Property, Plant & Equipment	-	139.72	136	148.09	1,245	1,077
Long-Term Investments	-	735.54	429.13	640.26	2.78	3.28
Other Intangible Assets	-	0.09	0.73	1.99	6.31	6.88
Long-Term Deferred Tax Assets	-	-	-	-	13.55	-
Other Long-Term Assets	-	22.82	28.11	29.57	79.75	34.77
Total Assets	-	1,237	904.46	1,096	1,959	1,621
Accounts Payable	-	136.24	154.43	233.7	280	309.53
Accrued Expenses	-	21.96	16.54	23.18	32.34	42.04
Short-Term Debt	-	59	50.42	56.64	110.47	236.37
Current Portion of Long-Term Debt	-	0.33	-	-	38.76	33.07
Current Portion of Leases	-	2.8	2.43	2.47	1.97	-
Other Current Liabilities	-	8.11	6.65	14.23	25.25	15.13
Total Current Liabilities	-	228.44	230.48	330.21	488.79	636.14
Long-Term Debt	-	1.31	-	-	92.91	144.4
Long-Term Leases	-	12.4	3.57	6.02	8.49	-
Pension & Post-Retirement Benefits	-	6.37	6.8	9.03	12.96	10.16
Long-Term Deferred Tax Liabilities	-	-	-	-	-	32.3
Other Long-Term Liabilities	-	7.39	7.76	11.17	12.78	6.29
Total Liabilities	-	255.9	248.6	356.44	615.92	829.29
Common Stock	-	294.57	262.47	247.03	247.03	247.03
Additional Paid-In Capital	-	1,170	777.24	680	860.21	680
Retained Earnings	-	-486.52	-386.85	-190.93	-236.18	-138.49
Comprehensive Income & Other	-	2.81	3	3.43	3.84	2.94
Total Common Equity	1,157	981.04	655.85	739.53	874.9	791.48
Minority Interest	-	-	-	-	468.29	-
Shareholders' Equity	1,157	981.04	655.85	739.53	1,343	791.48
Total Liabilities & Equity	-	1,237	904.46	1,096	1,959	1,621
Total Debt	78.33	75.83	56.42	65.12	252.59	413.85
Net Cash (Debt)	-67.82	-75.39	-55.16	-64.89	-226.54	-405.01
Net Cash Per Share	-2.32	-2.81	-2.15	-2.63	-9.17	-16.40
Filing Date Shares Outstanding	29.41	29.46	26.25	24.7	24.7	24.7
Total Common Shares Outstanding	29.41	29.46	26.25	24.7	24.7	24.7
Working Capital	-	110.33	80.01	-54.15	123.04	-137.31
Book Value Per Share	39.30	33.30	24.99	29.94	35.42	32.04
Tangible Book Value	1,157	980.95	655.12	737.55	868.59	784.6
Tangible Book Value Per Share	39.30	33.30	24.96	29.86	35.16	31.76
Land	-	15.13	15.13	15.13	187.13	187.13
Buildings	-	38.89	38.89	38.45	447.98	442.72
Machinery	-	166.2	160.19	156.49	771.88	697.3
Construction In Progress	-	-	-	-	151.07	6.76

Source: S&P Global Market Intelligence. Standard template. Financial Sources.